Search results
Results from the WOW.Com Content Network
The COVID-19 pandemic in Tanzania was a part of the ongoing worldwide pandemic of coronavirus disease 2019 ( COVID-19) caused by severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ).
As of 2 July, at least one case of COVID-19 has been reported in every country in South Asia. Afghanistan, Bangladesh, Pakistan and Maldives have implemented lockdowns, Sri Lanka has responded with quarantine curfews while India and Nepal have declared a country-wide lockdown. Countries have also instituted various levels of restrictions on ...
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. [1] The United States donated over 1.5 ...
In a major breakthrough for one of the world's last countries to embrace COVID-19 vaccines, Tanzania’s president kicked off the nation’s vaccination campaign Wednesday by publicly receiving a ...
The timeline of the COVID-19 pandemic lists the articles containing the chronology and epidemiology of SARS-CoV-2, [1] the virus that causes the coronavirus disease 2019 ( COVID-19) and is responsible for the COVID-19 pandemic .
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies. In April 2022, the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) approved the vaccine, being the first in the world to do so.
COVID-19 vaccination in Algeria; Date: 29 January 2021: Location: vaccination clinics: Cause: COVID-19 pandemic: Participants: 2,500,000 doses administered Sputnik V and Oxford-AstraZeneca (6 June 2021) 2,500,000 Total vaccinated people (to which the first and second dose of vaccine were administered) Footage: https://corona-dz.live/
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector COVID-19 vaccine developed by the United States-based pharmaceutical company ImmunityBio. [2] [1] ImmunityBio